John C. Keel

John C. Keel

Auto-generated profile, based on publicly available information

John C. Keel

Emory Orthopedics/Spine Center, 59 Executive Park South NE, Atlanta, GA 30329, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2001 in Clinical Neurophysiology
Verified
Journal Article
Closed access
JKJohn C Keel
John C Keel
MSMark J Smith
Mark J Smith
EWEric M Wassermann
Eric M Wassermann

1 December 1999 in Neurology
Verified
Journal Article
Closed access
PDF file
MSM.J. Smith
M.J. Smith
JKJ.C. Keel
J.C. Keel
BGB.D. Greenberg
B.D. Greenberg
LAL.F. Adams
L.F. Adams
PSP.J. Schmidt
P.J. Schmidt
EWE.M. Wassermann
E.M. Wassermann
Objective: To determine whether there are menstrual cycle–related effects on cortical excitability in normal women. Background: Ovarian steroid hormones affect neurotransmission in the brain. Data from animal experiments have shown that progesterone metabolites enhance the action of gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in the cortex, producing benzodiazepine-like (e.g., diazepam and lorazepam) physiologic and behavioral effects. Estradiol has excitatory effects on measures of neuronal excitability, possibly acting through the glutamate system. These effects have been difficult to detect in women using conventional techniques. However, recently, paired transcranial magnetic stimulation (TMS) has been used to detect the effects of GABAergic and glutamatergic drugs in humans. We used this method to measure the effects of the menstrual cycle in normal women. Methods: We tested 13 healthy women during the follicular (low-progesterone) and luteal (high-progesterone) phases of the menstrual cycle using paired TMS. The effect of a subthreshold conditioning pulse on the cortex was tested by measuring the response to a second suprathreshold test pulse and comparing it with the response elicited by the test pulse administered alone. Results: Conditioning TMS produced more inhibition in the luteal phase than in the follicular phase (p = 0.01), of similar magnitude to the reported effect of benzodiazepine drugs. Conclusions: This study provides the first direct evidence of changes in the excitability of a cortical network with the menstrual cycle. The results also show a potential confound for studies using transcranial magnetic stimulation in populations that include menstruating women.

11 January 2000 in Neurology
Verified
Journal Article
Closed access
PDF file
BGB.D. Greenberg
B.D. Greenberg
UZU. Ziemann
U. Ziemann
GCG. Corá-Locatelli
G. Corá-Locatelli
AHA. Harmon
A. Harmon
DMD.L. Murphy
D.L. Murphy
EWE.M. Wassermann
E.M. Wassermann
Objective: To assess cortical inhibitory and excitatory mechanisms in obsessive–compulsive disorder (OCD). Background: Transcranial magnetic stimulation (TMS) studies have found decreased neuronal inhibition and a reduced cortical silent period in the primary motor area in Tourette’s syndrome, focal dystonia, and other disorders believed to involve dysfunction of subcortical structures, including the basal ganglia. Dysfunction of the basal ganglia and linked regions also has been implicated in OCD, which has significant clinical and familial overlap with tic disorders. Methods: We applied the TMS techniques previously used in Tourette’s syndrome to a group of 16 OCD patients (seven unmedicated) and 11 age-matched healthy volunteers extensively screened for psychopathology. Measures of motor cortex excitability included resting and active motor threshold, cortical silent period duration, and intracortical inhibition and facilitation using a paired-pulse TMS technique with a subthreshold conditioning stimulus. Results: Similar to recent findings in Tourette’s syndrome and focal dystonia, this study reports significantly decreased intracortical inhibition (ICI) relative to the volunteers at interstimulus intervals from 2 to 5 msec. We also found decreased active and resting motor evoked potential threshold in the OCD patients, another indication of increased cortical excitability. Neither abnormality appeared medication related. The decreases in ICI and motor threshold were greatest in OCD patients with comorbid tics, but remained significant in patients without tics. Conclusions: The data suggest abnormal cortical excitability in obsessive–compulsive disorder. These findings are congruent with the hypothesis that Tourette’s syndrome and obsessive–compulsive disorder (OCD) are analogous disorders with overlapping dysfunction in corticobasal circuits. Patients with tic-related OCD may have more abnormal motor cortex excitability than OCD patients without tics.

1 October 2019 in The Spine Journal
Verified
Journal Article
Open access
JKJad G. Khalil
Jad G. Khalil
MSMatthew Smuck
Matthew Smuck
TKTheodore Koreckij
Theodore Koreckij
JKJohn Keel
John Keel
DBDouglas Beall
Douglas Beall
SGSteven Garfin
Steven Garfin
Current literature suggests that degenerated or damaged vertebral endplates are a significant cause of chronic low back pain (LBP) that is not adequately addressed by standard care. Prior 2-year data from the treatment arm of a sham-controlled randomized controlled trial (RCT) showed maintenance of clinical improvements at 2 years following radiofrequency (RF) ablation of the basivertebral nerve (BVN). The purpose of this RCT was to compare the effectiveness of intraosseous RF ablation of the BVN to standard care for the treatment of chronic LBP in a specific subgroup of patients suspected to have vertebrogenic related symptomatology. A prospective, parallel, open label RCT was conducted at 20 U.S. sites. A total of 140 patients with chronic LBP of at least 6 months duration, with Modic Type 1 or 2 vertebral endplate changes between L3 and S1, were randomized 1:1 to undergo either RF ablation of the BVN or continue standard care. Oswestry Disability Index (ODI) was collected at baseline, 3, 6, 9, and 12-months postprocedure. Secondary outcome measures included a 10-point Visual Analog Scale (VAS) for LBP, ODI and VAS responder rates, SF-36, and EQ-5D-5L. The primary endpoint was a between-arm comparison of the mean change in ODI from baseline to 3 months post-treatment. Patients were randomized 1:1 to receive RF ablation or to continue standard care. Self-reported patient outcomes were collected using validated questionnaires at each study visit. An interim analysis to assess for superiority was prespecified and overseen by an independent data management committee when a minimum of 60% of patients had completed their 3-month primary endpoint visit. The interim analysis showed clear statistical superiority (p<.001) for all primary and secondary patient-reported outcome measures in the RF ablation arm compared with the standard care arm. This resulted in a data management committee recommendation to halt enrollment in the study and offer early cross-over to the control arm. These results are comprised of the outcomes of the 104 patients included in the intent-to-treat analysis of the 3-month primary endpoint, which included 51 patients in the RF ablation arm and 53 patients in the standard care arm. Baseline ODI was 46.1, VAS was 6.67, and mean age was 50 years. The percentage of patients with LBP symptoms ≥5 years was 67.3%. Comparing the RF ablation arm to the standard care arm, the mean changes in ODI at 3 months were -25.3 points versus -4.4 points, respectively, resulting in an adjusted difference of 20.9 points (p<.001). Mean changes in VAS were -3.46 versus -1.02, respectively, an adjusted difference of 2.44 cm (p<.001). In the RF ablation arm, 74.5% of patients achieved a ≥10-point improvement in ODI, compared with 32.7% in the standard care arm (p<0.001). Minimally invasive RF ablation of the BVN led to significant improvement of pain and function at 3-months in patients with chronic vertebrogenic related LBP.

1 January 2015 in Pain Medicine
Verified
Journal Article
Closed access
PDF file
JGJatinder Gill
Jatinder Gill
MAMoris Aner
Moris Aner
NJNagda Jyotsna
Nagda Jyotsna
JKJohn C. Keel
John C. Keel
TSThomas T. Simopoulos
Thomas T. Simopoulos

11 January 2012 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
PNPushpa Narayanaswami
Pushpa Narayanaswami
ASAndrew J. Spieker
Andrew J. Spieker
PMPhillip Mongiovi
Phillip Mongiovi
JKJohn C. Keel
John C. Keel
SMStefan C. Muzin
Stefan C. Muzin
SRSeward B. Rutkove
Seward B. Rutkove